Oxford Asset Management’s Phibro Animal Health PAHC Stock Holding History

Oxford Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,972	Closed	-$485K	–	651
2025 Q2	$485K	Buy	+18,972	New	+$414K	0.16%	210
2020 Q1	–	Sell	-37,933	Closed	-$942K	–	972
2019 Q4	$942K	Sell	37,933 -24,662	-39%	-$572K	0.03%	903
2019 Q3	$1.33M	Sell	62,595 -17,727	-22%	-$486K	0.03%	778
2019 Q2	$2.55M	Sell	80,322 -8,706	-10%	-$273K	0.05%	536
2019 Q1	$2.94M	Buy	89,028 +18,040	+25%	+$561K	0.06%	402
2018 Q4	$2.28M	Sell	70,988 -14,231	-17%	-$537K	0.06%	395
2018 Q3	$3.69M	Buy	85,219 +50,631	+146%	+$2.39M	0.08%	341
2018 Q2	$1.58M	Buy	+34,588	New	+$1.53M	0.03%	802
2018 Q1	–	Sell	-10,331	Closed	-$349K	–	1823
2017 Q4	$349K	Sell	10,331 -42,340	-80%	-$1.5M	0.01%	1298
2017 Q3	$1.95M	Buy	52,671 +34,554	+191%	+$1.3M	0.04%	633
2017 Q2	$671K	Buy	+18,117	New	+$591K	0.01%	1022

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oxford Asset Management's PAHC Position: Q3 2025 in Review

Oxford Asset Management sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 18,972 shares — an estimated $485K sold.

Oxford Asset Management first reported a position in PAHC in Q2 2017 and held it in 11 quarters. The position peaked at $3.69M in Q3 2018. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

Oxford Asset Management reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
Oxford Asset Management sold 18,972 Phibro Animal Health shares in Q3 2025, an estimated $485K.
Oxford Asset Management first reported a position in Phibro Animal Health in Q2 2017 and held it in 11 quarters.
Oxford Asset Management's Phibro Animal Health position peaked at $3.69M in Q3 2018.
218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.